* Orthofix Medical Inc OFIX.OQ OFIX.O is expected
to show a
rise in quarterly revenue when it reports results on February
25.
* The Lewisville Texas-based company is expected to report
a
6.2% increase in revenue to $124.875 million from $117.62
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Orthofix Medical
Inc is
for earnings of 13 cents per share. For the same quarter last
year, the company reported earnings of 44 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Orthofix
Medical
Inc is $53.5, about 41.8% above its last closing price
of $31.12.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 0.11 0.11 0.10 Missed -10.4
Jun. 30 2021 0.13 0.11 0.32 Beat 190.9
Mar. 31 2021 0.01 0.02 0.17 Beat 709.5
Dec. 31 2020 0.17 0.19 0.44 Beat 126.8
Sep. -0.29 -0.36 0.31 Beat 185.2
30 2020
Jun. 30 2020 -1.07 -1.08 -0.59 Beat 45.4
Mar. 31 2020 0.07 0.06 0.09 Beat 50
Dec. 31 2019 0.58 0.58 0.51 Missed -12.4
This summary was machine generated February 23 at 16:41 GMT.
All figures in US dollars unless otherwise stated